EUVIMEDEUVIMED entdecken
Open Access

The Efficacy of Electrochemotherapy with Dacarbazine on Melanoma Cells

Alaaddin Coskun iD, Handan Kayhan, Fatih Senturk, Meric Arda Esmekaya, Ayse Gulnihal Canseven

Bioelectricity · 01.06.2024 · 6 (2) · 118-125

DOI: 10.1089/bioe.2023.0041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioelectricity, online erschienen am 12.06.2024. Verfasst von Alaaddin Coskun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics, Faculty of Medicine, Gazi University, Ankara, Turkey. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Electrochemotherapy (ECT) involves locally applying electrical pulses to permeabilize cell membranes, using electroporation (EP). This process enhances the uptake of low-permeant chemotherapeutic agents, consequently amplifying their cytotoxic effects. In melanoma treatment, dacarbazine (DTIC) is a cornerstone, but it faces limitations because of poor cell membrane penetration, necessitating the use of high doses, which, in turn, leads to increased side effects. In our study, we investigated the effects of DTIC and EP, both individually and in combination, on the melanoma cell line (SK-MEL-30) as well as human dermal fibroblasts (HDF) using in vitro assays. First, the effects of different DTIC concentrations on the viability of SK-MEL-30 and HDF cells were determined, revealing that DTIC was more effective against melanoma cells at lower concentrations, whereas its cytotoxicity at 1000 μM was similar in both cell types. Next, an ideal electric field strength of 1500 V/cm achieved a balance between permeability (84%) and melanoma cell viability (79%), paving the way for effective ECT. The combined DTIC-EP (ECT) application reduced IC 50 values by 2.2-fold in SK-MEL-30 cells and 2.7-fold in HDF cells compared with DTIC alone. In conclusion, ECT not only increased DTIC’s cytotoxicity against melanoma cells but also affected healthy fibroblasts. These findings emphasize the need for cautious, targeted ECT management in melanoma therapy.

Schlagwörter

Stichwörter der Autor:innen

dacarbazineelectrochemotherapyhuman dermal fibroblastsmelanoma cell lines

Autor:innen und Institutionen

  • Department of Biophysics, Faculty of Medicine, Gazi University, Ankara, Turkey.
  • Department of Adult Hematology, Faculty of Medicine, Gazi University, Ankara, Turkey.
  • Department of Biophysics, Faculty of Medicine, Duzce University, Duzce, Turkey.

ORCID-Profile: Alaaddin Coskun

Zitieren

APA

Coskun, A., Kayhan, H., Senturk, F., Esmekaya, M. A., & Canseven, A. G. (2024). The Efficacy of Electrochemotherapy with Dacarbazine on Melanoma Cells. Bioelectricity, 6(2), 118-125. https://doi.org/10.1089/bioe.2023.0041

Vancouver

Coskun A, Kayhan H, Senturk F, Esmekaya MA, Canseven AG. The Efficacy of Electrochemotherapy with Dacarbazine on Melanoma Cells. Bioelectricity. 2024;6(2):118-125. doi:10.1089/bioe.2023.0041

BibTeX
@article{Coskun2024,
  author = {Coskun, Alaaddin and Kayhan, Handan and Senturk, Fatih and Esmekaya, Meric Arda and Canseven, Ayse Gulnihal},
  title = {The Efficacy of Electrochemotherapy with Dacarbazine on Melanoma Cells},
  journal = {Bioelectricity},
  year = {2024},
  volume = {6},
  number = {2},
  pages = {118--125},
  doi = {10.1089/bioe.2023.0041}
}
Kostenlos starten →